Cancer Health Treatment Update The Next Cancer Breakthroughs An inside look at five research developments that have the potential to transform the treatment of cancer. Libtayo Immunotherapy Improves Cervical Cancer Survival Study participants who received Libtayo had a 31% lower risk of death than those treated with chemotherapy. Less Prostate Cancer Screening Tied to More Advanced Diagnoses States with greater decreases in prostate cancer screening saw more diagnoses of metastatic cancer. Among Cancer Survivors, Walking Pace May Predict Mortality Risk Cancer survivors who walk slowly are at greater risk of death compared with those who walk more briskly. Advertisement For Cancer Screening, COVID-19 Creates Obstacles, Opportunities Efforts to reach patients during the COVID-19 pandemic has led to both setbacks and new innovations in cancer screening.  After a Year of COVID-19, Light at the End of the Tunnel COVID-19 cases, hospitalizations and deaths continue to drop in the United States, but a global pandemic cannot be defeated in one country. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed Missing One Routine Mammogram Increases Risk of Breast Cancer Death Enlarged Lymph Nodes After COVID-19 Vaccine May Be Mistaken for Cancer Metastasis Survey Finds COVID-19 Vaccine Hesitancy Among Those With Blood Cancer The Pandemic Is Harming Women’s Health Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Libtayo for Basal Cell Carcinoma Newsfeed Missing One Routine Mammogram Increases Risk of Breast Cancer Death Enlarged Lymph Nodes After COVID-19 Vaccine May Be Mistaken for Cancer Metastasis Survey Finds COVID-19 Vaccine Hesitancy Among Those With Blood Cancer The Pandemic Is Harming Women’s Health Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Libtayo for Basal Cell Carcinoma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: